Novaliq Gmbh

Novaliq Gmbh company information, Employees & Contact Information

Explore related pages

Related company profiles:

Novaliq is a pharmaceutical company focusing on the development and commercialization of first- and best-in-class ocular therapeutics based on EyeSol®, the first water-free technology worldwide for ophthalmology products. With an initial focus on dry eye disease (DED), Novaliq offers an industry-leading portfolio addressing today’s unmet medical needs of millions of patients with eye disease. With an initial focus on dry eye disease (DED), Novaliq offers an industry-leading portfolio addressing today’s unmet medical needs of millions of patients with eye disease. NOV03 and CyclASol® are the two late stage development compounds. NOV03 is the first drug developed to treat evaporative DED associated with meibomian gland dysfunction in a highly effective way. CyclASol®, an ophthalmic solution of 0.1% cyclosporine A in EyeSol®, is an anti-inflammatory and immunomodulating drug for the treatment of aqueous deficient DED. Both compounds have shown superior clinical benefit, with an onset of action and an excellent tolerability profile. NovaTears® water-free eye drops for dry eye disease have CE certification and are commercialized in Australia/New Zealand by AFT Pharmaceuticals and in Europe as EvoTears® by Ursapharm. Novaliq is headquartered in Heidelberg, Germany and has an office in Cambridge, MA, USA. The long-term shareholder is dievini Hopp BioTech Holding, an active investor in Life and Health Sciences companies.

Company Details

Employees
23
Founded
-
Address
Im Neuenheimer Feld 515, Heidelberg,69120,germany
Phone
+49 6221 50259-0
Email
in****@****liq.com
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
Heidelberg
Looking for a particular Novaliq Gmbh employee's phone or email?

Novaliq Gmbh Questions

News

Breakthrough in Ophthalmology! Hengrui’s Heng Qin® (Perfluorohexyloctane Eye Drops) Approved as First Treatment for Dry Eye Disease Associated with MGD - Business Wire

Breakthrough in Ophthalmology! Hengrui’s Heng Qin® (Perfluorohexyloctane Eye Drops) Approved as First Treatment for Dry Eye Disease Associated with MGD Business Wire

Bausch + Lomb and Novaliq Announce U.S. FDA Filing Acceptance for Investigational Treatment NOV03 (Perfluorohexyloctane) - PR Newswire

Bausch + Lomb and Novaliq Announce U.S. FDA Filing Acceptance for Investigational Treatment NOV03 (Perfluorohexyloctane) PR Newswire

FDA approves Novaliq's cyclosporine ophthalmic solution for treatment of signs and symptoms of dry eye disease - Optometry Times

FDA approves Novaliq's cyclosporine ophthalmic solution for treatment of signs and symptoms of dry eye disease Optometry Times

Novaliq Announces FDA Approval of VEVYE™ (Cyclosporine Ophthalmic Solution) 0.1% for the Treatment of the Signs and Symptoms of Dry Eye Disease - BioSpace

Novaliq Announces FDA Approval of VEVYE™ (Cyclosporine Ophthalmic Solution) 0.1% for the Treatment of the Signs and Symptoms of Dry Eye Disease BioSpace

Harrow to acquire products from Santen, Novaliq - Healio

Harrow to acquire products from Santen, Novaliq Healio

Novaliq’s dry eye disease therapy receives US FDA approval - Pharmaceutical Technology

Novaliq’s dry eye disease therapy receives US FDA approval Pharmaceutical Technology

Novaliq Receives Positive CHMP Opinion for Vevizye® in Dry Eye Disease - Business Wire

Novaliq Receives Positive CHMP Opinion for Vevizye® in Dry Eye Disease Business Wire

Cyclosporine Superior to Vehicle, Improves Corneal Staining in Dry Eye Disease - HCPLive

Cyclosporine Superior to Vehicle, Improves Corneal Staining in Dry Eye Disease HCPLive

Bausch + Lomb, Novaliq announce FDA approval of perfluorohexyloctane ophthalmic solution for treatment of dry eye disease - Ophthalmology Times

Bausch + Lomb, Novaliq announce FDA approval of perfluorohexyloctane ophthalmic solution for treatment of dry eye disease Ophthalmology Times

FDA to Review Novel Cyclosporine Ophthalmic Solution for Dry Eye Disease - Medical Professionals Reference

FDA to Review Novel Cyclosporine Ophthalmic Solution for Dry Eye Disease Medical Professionals Reference

Bausch Health Licenses Novaliq's NOV03 Investigational Treatment For Dry Eye Disease Associated With Meibomian Gland Dysfunction - PR Newswire

Bausch Health Licenses Novaliq's NOV03 Investigational Treatment For Dry Eye Disease Associated With Meibomian Gland Dysfunction PR Newswire

Novaliq, AFT Pharmaceuticals ink licensing deal for NovaTears dry eye therapy - Drug Delivery Business

Novaliq, AFT Pharmaceuticals ink licensing deal for NovaTears dry eye therapy Drug Delivery Business

Novaliq receives positive CHMP opinion for dry eye treatment Vevizye - Optometry Times

Novaliq receives positive CHMP opinion for dry eye treatment Vevizye Optometry Times

Novaliq, Jiangsu Hengrui focus on treatment of dry eye disease - BioSpectrum Asia

Novaliq, Jiangsu Hengrui focus on treatment of dry eye disease BioSpectrum Asia

Novaliq and Laboratoires Théa Announce Partnership and EU Approval for Vevizye - Business Wire

Novaliq and Laboratoires Théa Announce Partnership and EU Approval for Vevizye Business Wire

Reviewing what is in the anterior segment topical ophthalmic pipeline - Optometry Times

Reviewing what is in the anterior segment topical ophthalmic pipeline Optometry Times

Harrow Acquires U.S. and Canadian Commercial Rights to VEVYE® (Cyclosporine Ophthalmic Solution) 0.1% from Novaliq - Business Wire

Harrow Acquires U.S. and Canadian Commercial Rights to VEVYE® (Cyclosporine Ophthalmic Solution) 0.1% from Novaliq Business Wire

Top Novaliq Gmbh Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant